The RAINBO MMRd-GREEN trial (GCIG/DGOG/ENGOT-EN14(2)): A phase III trial on the addition of adjuvant durvalumab to radiotherapy in patients with high-risk MMRd endometrial cancer

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要